How to Reconstitute Peptides: RUO Lab Record & COA Handoff Guide

Supplier handoff before reconstitution#

If this page is being used after a supplier comparison, keep the procurement and preparation records connected. For Canadian research buyers, the common handoff is: verify the current supplier lot, inspect the COA, confirm the fill amount, then document solvent and concentration decisions. Product-record starting points include bacteriostatic water for solvent procurement context, BPC-157, TB-500, semaglutide, tirzepatide, and retatrutide. These are documentation-review paths only; this guide does not provide dosing, injection, treatment, or personal-use instructions.

Quick answer: peptide reconstitution as a lab record#

How to reconstitute peptides, in a research-use-only lab record, means dissolving a lyophilised research peptide into a defined solvent volume and converting it into a labelled working solution with traceable documentation. For Northern Compound, the useful output is not a casual "how much water" note. It is a batch-linked record that answers six questions before the vial is opened: which lot is being prepared, which solvent was selected, what volume was added, what final concentration resulted, how the vial was labelled, and where the post-reconstitution storage/discard notes live.

Use the reconstitution documentation handoff checklist below when connecting this page to procurement assets. For a spreadsheet-style arithmetic record, use the research peptide reconstitution calculation worksheet before a prepared stock enters the batch file. It gives older COA, receiving, storage, sterility/endotoxin, supplier-red-flag, and comparison pages a single forward link target for solvent choice, concentration math, vial labelling, and post-reconstitution documentation without drifting into medical, dosing, injection, or personal-use advice.

If you are arriving from a supplier review, COA checklist, cold-chain log, sterility/endotoxin screen, supplier-red-flag review, or GLP-1 comparison, treat this as the neutral peptide reconstitution guide in the record set: document the parent lot first, then record solvent, volume, resulting concentration, label text, storage assumption, and any exception path in the same batch file.

Peptide reconstitution record quick-reference#

Use this quick-reference before a vial is opened. It is designed for RUO documentation handoff, not dosing, injection, treatment, compounding, or personal-use instruction.

Peptide reconstitution search-intent map#

Readers use different phrases for the same documentation problem. This map keeps the page useful for quick GSC-style questions without turning the article into use guidance.

Introduction#

Understanding how to reconstitute peptides is a core research-use-only handling and documentation requirement for lyophilised compounds. Peptides arrive in sealed glass vials as dry, freeze-dried powder. Before a laboratory can prepare a working solution for an approved non-clinical protocol, that powder must be dissolved into a defined liquid matrix and documented clearly enough that downstream assay results remain interpretable. This peptide reconstitution guide treats reconstitution as a laboratory recordkeeping problem: solvent choice, concentration math, vial labelling, storage assumptions, and COA handoff all need to stay connected.

This resource covers the reconstitution workflow as a laboratory handling and documentation reference. It starts with the chemistry and physics of lyophilisation, explains why solvent choice matters, walks through the technique vocabulary with troubleshooting at each stage, and provides worked concentration calculations for eight commonly researched peptides including BPC-157, TB-500, semaglutide, and tirzepatide. It also covers storage physics, freeze-thaw damage, degradation recognition, and how to calculate remaining volume from a partially used vial.

All content here is for research and educational purposes only. Nothing in this guide constitutes medical advice, dosing guidance, injection training, treatment recommendation, route guidance, compounding instruction, or a recommendation to self-administer any peptide compound. For the surrounding procurement and compliance records, pair this page with the COA verification checklist, vial inspection checklist, temperature excursion log, receiving SOP, batch documentation template, supplier scorecard, COA request email template, and RUO compliance checklist.

Canadian researchers typically receive sealed vials of lyophilised powder from domestic suppliers such as Lynx Labs. The reconstitution principles are supplier-independent, but the quality of the lyophilised material affects how readily it dissolves, how stable the resulting solution will be, and how reliably the declared mass matches actual contents. A batch-specific certificate of analysis is the baseline quality check before any reconstitution; the research peptide buyers guide explains what to look for and what HPLC purity figures mean.

Done correctly, reconstituting a single vial takes fewer than five minutes. Done poorly, it wastes material, breaks lot traceability, and introduces concentration errors that can make downstream research measurements impossible to interpret.

What Lyophilisation Is and Why It Matters for Peptide Stability#

Lyophilisation is the process of removing water from a biological compound by first freezing it and then reducing the surrounding pressure until the frozen water sublimes directly from solid to vapour, bypassing the liquid phase entirely. The term comes from the Greek for "fat-dissolving" but is now applied universally across biological and pharmaceutical compounds. For peptides, it is the preservation method of choice because it removes the aqueous environment that allows enzymatic degradation, microbial growth, and hydrolysis reactions to proceed.

The Physics of Sublimation#

At atmospheric pressure, water moves from solid to liquid to gas as temperature rises. Under vacuum, the phase diagram of water shifts in a way that eliminates the liquid phase entirely below a critical pressure. When the surrounding pressure drops below 611 Pascals (approximately 0.006 atmospheres), the triple point of water, solid water cannot exist in equilibrium with liquid water at any temperature. Ice converts directly to vapour. Industrial lyophilisers exploit this: they first freeze a peptide solution to roughly -40 to -80 degrees Celsius, then pull a vacuum and gently warm the shelf. Over many hours, the ice sublimes and is collected as vapour on a cold condenser. What remains in the vial is the dried peptide matrix, a porous cake that retains the three-dimensional geometry of the frozen solution.

The porous structure is important. Because the matrix was frozen as a liquid and had water removed in situ, the dried cake has a very high surface area relative to its mass. When reconstitution water is added, it contacts the peptide from multiple angles simultaneously, promoting rapid dissolution. It also means the cake is physically fragile. A vial that has been dropped or roughly handled may arrive with a broken or powderised cake rather than an intact porous structure. The peptide itself is generally undamaged by this, but powder settles differently from intact cake and researchers should swirl more gently to avoid generating foam.

Why Aqueous Stability Is the Core Problem#

Peptide bonds are vulnerable to hydrolysis in aqueous environments. Water molecules attack the amide linkages connecting amino acid residues, cleaving the chain. Temperature accelerates this. A peptide in solution at room temperature may lose meaningful activity within days. The same peptide as lyophilised powder, stored at or below room temperature with moisture excluded, may remain stable for years. This is not a marginal difference; it is the reason that every commercial peptide research product ships as powder rather than pre-dissolved liquid.

The removal of water also eliminates the liquid medium that bacteria, moulds, and yeasts require to grow. A dry vial with an intact rubber stopper and aluminium crimp is effectively a sterile, sealed container. The moment water is introduced during reconstitution, microbial growth becomes a risk again. This is why solvent choice and sterile technique at reconstitution both carry genuine consequences.

A second form of stability that lyophilisation provides is protection against oxidation. Several amino acid residues, including cysteine, methionine, and tryptophan, are susceptible to oxidative damage in solution. In the dry state, oxygen diffusion through the peptide matrix is extremely slow. Suppliers who flush the vial headspace with nitrogen or argon before sealing extend this protection further. When you open a vacuum-sealed peptide vial, the slight inward pull on the plunger as the needle enters reflects the inert gas or sub-atmospheric pressure inside; this is a positive sign indicating the seal was intact.

The practical implication: do not reconstitute a vial speculatively. Once water is introduced, the countdown begins. A lyophilised vial sitting unused retains its activity. The same compound in solution, stored for months, almost certainly does not. This reconstitution guide covers the physical chemistry and stability considerations in detail if you want to go deeper on the science.

Choosing Your Solvent: Bacteriostatic Water, Sterile Water, and Acetic Acid#

The solvent introduced during reconstitution is the first irreversible decision in the process. The three options that appear in peptide research contexts are bacteriostatic water, sterile water for injection, and dilute acetic acid (typically 0.1 to 1 percent). Each has a different application profile, different compatibility with peptide compounds, and different risk profile if misapplied.

Bacteriostatic Water#

Bacteriostatic water for injection (BAC water) is sterile water containing benzyl alcohol as a preservative, commonly stated as 0.9 percent in many product records. The preservative can support repeated-access research workflows, but it does not make the vial an invisible or indefinitely safe variable. Treat the solvent as its own lot-controlled material with label, expiry, storage, first-puncture, and endpoint-compatibility records.

Many peptide research files use BAC water as a practical aqueous diluent, but compatibility should be documented rather than assumed. Benzyl alcohol, pH, osmolality, storage time, and container effects can matter in sensitive cell, microbial, inflammatory, mitochondrial, skin-barrier, or viability endpoints. Before a solvent lot enters the batch file, run the bacteriostatic water lot release checklist and keep the final accept, clarify, quarantine, reject, or endpoint-exclusion decision with the peptide record.

In Canada, BAC water is regulated as a pharmaceutical product. It is sourced through compounding pharmacies or domestic research suppliers. The handling notes below cover sourcing, the 28-day preservative window, and the benzyl alcohol chemistry in detail.

Sterile Water for Injection#

Sterile water for injection is water that has been sterilised (by autoclaving or filtration) and packaged in single-use sealed vials. It contains no preservative. Once the stopper is pierced, the contents are no longer guaranteed sterile, and any remaining water should be treated as single-use. It is appropriate for single-dose preparations where the entire reconstituted vial will be used in one session, or where BAC water is genuinely unavailable.

Sterile water is not suitable for multi-dose protocols. It is slightly hypotonic relative to physiological fluids. At the small volumes typical in peptide research, this is not a practical concern, but it is why sterile water for injection differs from the distilled water used in a chemistry lab.

Dilute Acetic Acid#

Dilute acetic acid (0.1 to 1 percent in sterile water) is used for a subset of peptides that are poorly soluble in neutral aqueous conditions, or that tend to aggregate in standard BAC water. The acidic environment shifts the pH to roughly 3-4.5, altering the electrostatic charge distribution on the peptide and improving solubility for compounds that carry a net positive charge at their isoelectric point under neutral conditions.

The most commonly cited compound in research contexts that benefits from acetic acid reconstitution is IGF-1 LR3. Standard practice involves reconstituting in a small volume (0.1 to 0.5 mL) of 0.1 percent acetic acid to dissolve the powder, then diluting to working concentration with BAC water. The acid step ensures full dissolution; the BAC water dilution restores a more physiologically compatible pH and provides the preservative needed for multi-dose use.

For all eight peptides covered in this guide, acetic acid reconstitution is not required in the documentation examples. If a peptide dissolves poorly in BAC water and the research literature indicates acetic-acid compatibility, record the rationale, acid concentration, initial volume, dilution volume, final pH assumption if known, and source reference before preparing a working solution. Never use undiluted glacial acetic acid (99 percent), which would denature peptide material instantly.

Equipment Checklist: What to Assemble Before Opening Any Vial#

Proper reconstitution requires assembling all tools before anything is opened. Beginning the process and then searching for an alcohol swab is a contamination risk. Set up the workspace completely first.

Bacteriostatic water. A 30 mL multi-use vial is economical for researchers working with multiple peptide vials or performing frequent reconstitutions. A 10 mL vial suffices for occasional use. Inspect for clarity and expiry date before opening.

The peptide vial. Inspect for visible cracks in the glass, stopper damage, or signs of moisture inside the vial. A small colour change in the powder, or a clumped appearance that does not match a typical lyophilised cake, may indicate that moisture has entered during shipping. The powder of a properly lyophilised vial should be white to off-white, porous, and dry-looking. If there is any visible liquid or condensation inside the sealed vial, do not reconstitute; contact the supplier.

Graduated sterile transfer syringes. The examples below use U-100 unit markings as a volume-reference convention because many research records use those graduations for small-volume calculations: 100 units equals 1 mL. For reconstituting a larger vial where the record calls for 5 to 10 mL of BAC water, a sterile 3 mL or 5 mL syringe with a separate needle is more practical for the transfer step. Keep the language in the batch file focused on measured aliquot volume, not administration.

Alcohol swabs (70 percent isopropyl alcohol). One per vial top, minimum. The 70 percent concentration matters: pure or 99 percent isopropyl evaporates too quickly to be fully effective as a surface disinfectant. Use individually wrapped sterile swabs, not a shared bottle and cloth.

A clean, hard, non-porous work surface. A glass cutting board wiped with 70 percent isopropyl, a stainless steel tray, or a clean enamel surface works well. Avoid fabric (absorbs contaminants), paper towel (fibres shed), or bare wood (porous and impossible to sanitise reliably).

A fine-tip permanent marker. Indelible, for labelling.

An opaque container or small box for storing the reconstituted vial in the fridge. Light degrades peptide solutions over time.

A sharps container. Used needles go directly into a sharps container. Do not recap needles. In Canada, most pharmacies accept sealed sharps containers for proper disposal under household hazardous waste programmes.

A calculator. Do the concentration arithmetic before touching either vial, and write it down.

Wash hands thoroughly with soap and water for at least 20 seconds before assembling the kit. If the workspace is shared or has been used recently for other purposes, wipe it down with fresh 70 percent isopropyl before anything sterile comes out of its packaging. Close windows, turn off overhead fans, and minimise airflow through the reconstitution space.

Insulin Syringe Units to Volume Conversion Reference#

The U-100 insulin syringe is the research standard for measuring and delivering small volumes of peptide solution. U-100 indicates the calibration: 100 units per millilitre, so each unit mark represents 0.01 mL. The full 100-unit (1 mL) scale covers most peptide research volumes effectively.

The conversion formula: Unit-mark volume = (target aliquot amount) divided by (concentration in the same units per mL), multiplied by 100.

Example: target aliquot amount is 250 mcg, concentration is 2.5 mg/mL (2,500 mcg/mL). Unit-mark volume = (250 divided by 2,500) times 100 = 10 units, or 0.10 mL.

The table below shows volume in mL and the corresponding amount at four common research concentrations. Use the worked examples in this guide to check the arithmetic for concentrations not listed here. Treat this as a calculation reference for research documentation, not as a recommendation to administer any peptide or choose a human dose.

When calculating an aliquot, round to the nearest readable unit mark and document the rounding. Finer gradations cannot be read reliably on a standard U-100 scale. If rounding introduces meaningful error, reconstitute with more solvent to create a lower concentration that maps to a larger, more readable measured volume for the research record.

Concentration Calculations for Eight Common Research Peptides#

The core formula is: Concentration (mg/mL) = mass (mg) divided by volume (mL). To find how much solvent to add: Volume to add (mL) = mass (mg) divided by target concentration (mg/mL). The worked examples below apply this to eight common research peptides.

1. BPC-157 (5 mg Vial)#

BPC-157 is a 15-amino acid stable gastric pentadecapeptide fragment, one of the most frequently reconstituted compounds in recovery-focused peptide research.

Option A (standard working concentration): Add 2 mL of BAC water to a 5 mg vial. Resulting concentration: 5 mg divided by 2 mL = 2.5 mg/mL (2,500 mcg/mL) A 250 mcg reference aliquot = 10 units on a U-100 volume scale (0.10 mL). Clean, readable, minimal measurement error for documentation.

Option B (high concentration): Add 1 mL of BAC water to a 5 mg vial. Resulting concentration: 5 mg divided by 1 mL = 5 mg/mL (5,000 mcg/mL) A 500 mcg reference aliquot = 10 units (0.10 mL). A 250 mcg reference aliquot = 5 units (0.05 mL), which is a small measured volume with higher proportional error.

Option A is cleaner for research documentation because a 250 mcg reference aliquot falls on the 10-unit mark, making the volume record easier to audit. Option B is useful when a protocol needs a more concentrated working solution, though the smaller measured volume increases proportional measurement error.

2. TB-500 (10 mg Vial)#

TB-500 is a synthetic analogue of the actin-sequestering peptide Thymosin Beta-4. Research vials are commonly supplied in 10 mg quantities.

Add 5 mL of BAC water to a 10 mg vial. Resulting concentration: 10 mg divided by 5 mL = 2 mg/mL (2,000 mcg/mL) A 2 mg reference aliquot = 100 units (1.0 mL, filling the full syringe scale) A 1 mg reference aliquot = 50 units (0.5 mL)

TB-500 is often documented at higher milligram-scale reference amounts than smaller recovery micropeptides, which is why the 5 mL reconstitution volume appears in many research records. The key editorial point is not route or use guidance: the record should show the target concentration, measured aliquot volume, calculation reviewer, and any protocol-specific volume limit before material is prepared.

3. Semaglutide (3 mg Vial)#

Semaglutide is a long-acting GLP-1 receptor agonist used in metabolic research. Research vials are available in 3 mg, 5 mg, and 10 mg quantities.

Add 6 mL of BAC water to a 3 mg vial. Resulting concentration: 3 mg divided by 6 mL = 0.5 mg/mL (500 mcg/mL) A 0.25 mg (250 mcg) reference aliquot = 50 units (0.5 mL) A 0.5 mg reference aliquot = 100 units (1.0 mL, full syringe scale)

The relatively dilute concentration is useful in research records because fractional-milligram reference aliquots map to larger, easier-to-read volumes. If an approved non-clinical protocol uses periodic sampling windows, the batch file should still confirm that the prepared solution remains inside the documented post-reconstitution storage window.

Important logistics: 6 mL of BAC water into a standard small glass vial will overflow. Confirm the vial vessel has at least 8 mL capacity before transferring the solvent, or reconstitute into a larger sterile vial. Some Lynx Labs semaglutide vials are supplied in larger vessels specifically to accommodate dilute reconstitution volumes.

4. Tirzepatide (5 mg Vial)#

Tirzepatide is a dual GIP and GLP-1 receptor agonist. Research vials are available in 5 mg and 10 mg quantities.

Add 5 mL of BAC water to a 5 mg vial. Resulting concentration: 5 mg divided by 5 mL = 1 mg/mL (1,000 mcg/mL) A 1 mg reference aliquot = 100 units (1.0 mL, full syringe scale) A 2.5 mg reference aliquot = 250 units (2.5 mL, requiring a larger graduated transfer syringe for accurate measurement)

As with semaglutide, confirm the vial has sufficient capacity for 5 mL of reconstitution volume before proceeding. For larger reference aliquots (2.5 mg and above), a 3 mL syringe graduated in 0.1 mL increments is more practical than a U-100 insulin syringe scale for record accuracy.

5. Retatrutide (10 mg, 30 mg, and 60 mg Vials)#

Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, available in multiple vial sizes. Concentration calculation depends on which vial is used.

10 mg vial:

• Add 2 mL: resulting concentration 5 mg/mL. A 5 mg reference aliquot = 100 units (1.0 mL).
• Add 5 mL: resulting concentration 2 mg/mL. A 2 mg reference aliquot = 100 units (1.0 mL).

30 mg vial:

• Add 6 mL: resulting concentration 5 mg/mL. A 5 mg reference aliquot = 100 units (1.0 mL).
• Add 10 mL: resulting concentration 3 mg/mL. A 3 mg reference aliquot = 100 units (1.0 mL).

60 mg vial:

• Add 12 mL: resulting concentration 5 mg/mL. Multiple full-scale 1.0 mL reference aliquots can be documented from one vial.
• Add 20 mL: resulting concentration 3 mg/mL. Finer aliquot gradation across a larger volume.

For large-volume vials, 12 to 20 mL of BAC water requires multiple BAC water vials or a single large-format BAC water vial. Plan the protocol consumption window so the full reconstituted volume is accounted for within the documented 28-30 day window, which may require smaller source vials or a different preparation schedule for the 30 mg and 60 mg formats.

6. CJC-1295 with DAC (2 mg Vial)#

CJC-1295 with DAC is a GHRH analogue with a drug affinity complex that extends its in vivo half-life well beyond that of unmodified CJC-1295.

Add 1 mL of BAC water to a 2 mg vial. Resulting concentration: 2 mg divided by 1 mL = 2 mg/mL (2,000 mcg/mL) A 200 mcg reference aliquot = 10 units (0.10 mL) A 500 mcg reference aliquot = 25 units (0.25 mL)

The high concentration keeps measured aliquot volumes compact in the lab record. CJC-1295 with DAC typically dissolves cleanly in BAC water and the solution should clear after gentle swirling; note any cloudiness or delay as an exception, not as a workaround.

7. Ipamorelin (5 mg Vial)#

Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist frequently researched alongside CJC-1295 with DAC.

Add 1 mL of BAC water to a 5 mg vial. Resulting concentration: 5 mg divided by 1 mL = 5 mg/mL (5,000 mcg/mL) A 500 mcg reference aliquot = 10 units (0.10 mL) A 200 mcg reference aliquot = 4 units (0.04 mL), which is a small measured volume with higher proportional measurement error.

For protocols documenting reference aliquots below 300 mcg where measurement precision matters, a 2 mL reconstitution is preferable: 2 mL produces: 2.5 mg/mL. A 200 mcg reference aliquot = 8 units (0.08 mL), which is more reliably measured.

Ipamorelin is also available in a pre-blended format with CJC-1295 from Lynx Labs, which eliminates the need to reconstitute two separate vials when using both compounds together.

8. Sermorelin (15 mg Vial)#

Sermorelin is a 29-amino acid synthetic GHRH analogue.

Add 10 mL of BAC water to a 15 mg vial. Resulting concentration: 15 mg divided by 10 mL = 1.5 mg/mL (1,500 mcg/mL) A 300 mcg reference aliquot = 20 units (0.20 mL) A 150 mcg reference aliquot = 10 units (0.10 mL)

The 15 mg vial is large by comparison to most research peptide vials, and the 10 mL reconstitution volume requires multiple punctures of the BAC water vial or use of a large-format BAC water vessel. A 5 mL transfer syringe is more practical here than drawing ten separate 1 mL syringes; fewer stopper punctures reduces both contamination risk and the time required.

How to Reconstitute Peptides: The Complete Step-by-Step Process#

The following sequence is the detailed workflow with troubleshooting at each stage. Read through the entire procedure before beginning. The same sequence applies regardless of peptide identity.

Step 1: Prepare the Workspace#

Wipe the work surface with 70 percent isopropyl alcohol using a clean, lint-free cloth or fresh paper towel. Allow the surface to fully air-dry before placing anything on it. Set out all materials in the order they will be used: BAC water vial, peptide vial, syringes, alcohol swabs, marker, sharps container. Close windows and doors to reduce airflow. Turn off overhead fans. Keep animals and uninvolved people out of the immediate area.

If something goes wrong at this step: If any sterile packaging falls on the floor after being dropped, discard it and use a fresh item. A compromised surface is a small loss compared to a contaminated reconstitution.

Step 2: Wash Hands#

Thorough handwashing with soap and water for at least 20 seconds. If nitrile gloves are available, put them on after washing and ensure they do not contact non-sterile surfaces before touching equipment.

Step 3: Allow the Peptide Vial to Reach Room Temperature#

Remove the peptide vial from cold storage and allow it to equilibrate at room temperature for 10 to 15 minutes. Cold glass accumulates surface condensation and creates differential pressure inside the vial that can make plunger control less precise during solvent transfer. Reducing static charge by bringing the vial to room temperature also prevents lyophilised powder from clinging to the stopper.

Troubleshooting: If the vial was stored frozen at -20 degrees Celsius, allow 30 minutes. Inspect the stopper and aluminium crimp for any damage that might have occurred during freeze storage. A loose crimp or a cracked stopper means the seal has been compromised; do not reconstitute.

Step 4: Calculate and Record the Target Concentration#

Before touching either vial, perform the concentration calculation: mass in mg divided by target volume in mL. Write the result down. Confirm that the resulting protocol reference aliquot falls on a clean U-100 volume mark. If it does not, adjust the reconstitution volume until the reference aliquot maps cleanly.

Troubleshooting: If no target reference amount falls cleanly on a unit mark at any convenient volume, choose the volume that places the aliquot on the nearest unit mark and note the rounding. An error of one unit (0.01 mL) at a concentration of 2.5 mg/mL represents 25 mcg; the lab should decide whether that precision is acceptable for the protocol record.

Step 5: Wipe Vial Stoppers#

Use a fresh alcohol swab to wipe the rubber stopper of the BAC water vial. Set the vial down and allow the alcohol to fully evaporate, approximately 30 seconds. Residual wet isopropyl on a stopper can be driven into the vial by the needle, introducing solvent contamination. Wipe the peptide vial stopper with a separate fresh swab. Allow that to dry as well. One swab per stopper is the standard; do not use the same swab on both vials.

Troubleshooting: If a stopper shows visible cracking, delamination, or loose rubber, the vial integrity may be compromised. If the aluminium crimp is damaged or off-centre, treat the vial as potentially compromised and do not use.

Step 6: Draw the Calculated Volume of BAC Water#

Insert the needle of the transfer syringe through the dried BAC water stopper. Draw slightly more than the target volume. Hold the syringe vertically with the needle pointing up, tap the barrel to dislodge air bubbles, then gently advance the plunger until you reach the exact target mark. Expel any overage back into the BAC water vial or into a sterile container.

Troubleshooting: If the BAC water vial is under partial vacuum (common as the vial is depleted), insert a vent needle or use a syringe with enough air pre-loaded to equalise pressure before drawing. Air bubbles affect volume accuracy and must be fully removed before solvent transfer into the peptide vial. A bubble at the 10-unit mark represents approximately 0.01 mL of uncertainty, which is a meaningful error at small aliquot volumes.

Step 7: Inject BAC Water into the Peptide Vial#

Insert the needle at a 45-degree angle through the rubber stopper of the peptide vial. Once the needle is inside, tilt it slightly so the tip is aimed at the inner glass wall above the level of the lyophilised powder. Depress the plunger slowly, allowing the water to run down the glass wall in a thin stream. Do not aim the stream directly at the powder cake.

A forceful hydraulic impact on the cake can shear peptide chains, cause foaming, and aerosolise fine powder into the headspace where it is effectively lost. The goal is a gentle, wall-directed flow that wets the cake gradually from below.

If the vial is under vacuum (as many lyophilised vials are), the plunger will be drawn forward automatically. In this case, allow the vacuum to pull the water in rather than pushing it. Vacuum-assisted transfer is gentler than manual plunger pressure and is the preferred method when available.

Troubleshooting: If the plunger is moving faster than expected due to strong vacuum, hold it steady at the target volume mark to prevent overfilling. If there is no vacuum and the plunger requires significant force, ensure the needle is not kinked and the stopper has been fully punctured rather than partially cored.

Step 8: Remove the Needle and Observe#

Withdraw the needle fully and place the used syringe directly into the sharps container. Do not set the used needle down on the work surface.

Observe the vial. The water should be wicking up into the porous cake within 30 to 60 seconds. Most peptides show visible dissolution beginning almost immediately as the liquid contacts the powder surface.

Troubleshooting: If there is foam in the vial from contact with the powder, allow it to fully settle before proceeding. Foam does not necessarily indicate degradation but makes clean drawing difficult. Do not shake.

Step 9: Swirl Gently, Never Shake#

Swirl the vial gently between thumb and forefinger for 10 to 20 seconds. The motion creates a mild convection current that distributes the water through the cake without generating shear stress. Alternatively, set the vial flat on the work surface and allow passive dissolution for 1 to 3 minutes. All eight peptides in this guide dissolve fully within that window under room temperature conditions.

Troubleshooting: If the solution is not fully clear after 3 minutes of gentle swirling, allow it to stand for an additional 5 minutes. Persistent cloudiness that does not resolve may indicate a poorly soluble peptide requiring an acetic acid pre-step (covered in the solvent section), a degraded starting material, or a manufacturing issue. Photograph the vial against a dark background and contact the supplier if cloudiness persists after 10 minutes of gentle agitation.

Step 10: Inspect the Solution#

Hold the vial against a bright light. The reconstituted solution should be clear, colourless, or faintly straw-coloured. No floating particles, no suspended fibres, no visible cloudiness, no clumping at the base of the vial. Any of these signs indicate a failed reconstitution; the vial should be discarded into a sharps container.

Step 11: Label and Refrigerate Immediately#

Using the permanent marker, write on the vial or on a small adhesive label: peptide name, concentration in mg/mL, and reconstitution date. Place the labelled vial in an opaque container and refrigerate at 2-8 degrees Celsius.

The opaque container serves two functions: it blocks light (which degrades peptide solutions, particularly those containing aromatic amino acids such as tryptophan), and it prevents the vial from being confused with other clear liquids in a shared refrigerator. Label every vial, every time, without exception.

Worked Reconstitution Examples: Five Peptides from Start to Finish#

BPC-157: 5 mg Vial, 2.5 mg/mL Target#

Vial contents: 5 mg lyophilised BPC-157. Target concentration: 2.5 mg/mL. Solvent volume required: 5 divided by 2.5 = 2.0 mL of BAC water.

Wipe both stoppers. Allow to dry. Draw exactly 2.0 mL into a 3 mL transfer syringe. Insert needle into peptide vial at 45 degrees, angle toward the glass wall, depress slowly over 5 to 10 seconds. Remove needle into sharps container. Observe dissolution: the porous BPC-157 cake wicks up the water quickly. Swirl gently for 15 seconds. Inspect: clear, colourless. Label: "BPC-157, 2.5 mg/mL, [date]." Refrigerate.

Reference aliquot arithmetic: 250 mcg = (250 divided by 2,500) times 100 = 10 units on a U-100 volume scale.

The full vial at 2 mL contains 200 units of volume. At 10 units per reference aliquot, this yields 20 aliquot records before the vial is exhausted. If the protocol consumes one aliquot per day, the vial is used within 20 days, inside the 28-30 day post-reconstitution window. See the BPC-157 research guide for the published literature context.

TB-500: 10 mg Vial, 2 mg/mL Target#

Vial contents: 10 mg lyophilised TB-500. Target concentration: 2 mg/mL. Solvent volume required: 10 divided by 2 = 5.0 mL of BAC water.

Use a 5 mL or 10 mL transfer syringe. Draw 5.0 mL of BAC water. Insert needle, angle toward the wall, and transfer solvent in a slow, steady stream. The larger cake volume of a 10 mg vial may take up to 3 minutes to fully dissolve; swirl gently every 30 seconds and be patient. Do not increase agitation if dissolution seems slow. Inspect: clear. Label: "TB-500, 2 mg/mL, [date]." Refrigerate.

Reference aliquot arithmetic: 1 mg = (1,000 divided by 2,000) times 100 = 50 units. A 2 mg reference aliquot = 100 units (1.0 mL, full syringe scale).

At one 2 mg reference aliquot per week, the vial provides 5 aliquot records across 5 weeks, but the 30-day post-reconstitution window may limit the usable protocol window. Plan accordingly. See the TB-500 guide for background on this compound in recovery research.

Semaglutide: 3 mg Vial, 0.5 mg/mL Target#

Vial contents: 3 mg lyophilised semaglutide. Target concentration: 0.5 mg/mL. Solvent volume required: 3 divided by 0.5 = 6.0 mL of BAC water.

Before drawing any water, confirm the peptide vial has sufficient capacity. A standard 3 mL glass vial holds only 3 mL of liquid; adding 6 mL would overflow. Semaglutide research vials from Lynx Labs are typically supplied in larger vessels (10 mL or 20 mL) to accommodate dilute reconstitution. If not, transfer the lyophilised powder to a larger sterile vial before reconstituting.

Draw 6.0 mL of BAC water (using a 10 mL syringe if available, or three 2 mL draws). Inject down the wall slowly. Semaglutide dissolves readily in BAC water. Swirl briefly. Inspect: clear or faintly opalescent. Label: "Semaglutide, 0.5 mg/mL, [date]." Refrigerate.

Reference aliquot arithmetic: 0.5 mg = (500 divided by 500) times 100 = 100 units (full 1 mL syringe scale). 0.25 mg = 50 units.

This vial yields six 0.5 mg reference aliquots. The batch file should still reconcile the protocol timeline with the 28-30 day post-reconstitution window rather than assuming the concentration math alone makes the material suitable.

Tirzepatide: 5 mg Vial, 1 mg/mL Target#

Vial contents: 5 mg lyophilised tirzepatide. Target concentration: 1 mg/mL. Solvent volume required: 5 divided by 1 = 5.0 mL of BAC water.

Confirm vial capacity as for semaglutide. Draw 5.0 mL. Inject slowly down the vial wall. Tirzepatide dissolves cleanly. Swirl for 15-20 seconds. Inspect: clear. Label: "Tirzepatide, 1 mg/mL, [date]." Refrigerate.

Reference aliquot arithmetic: 1 mg = 100 units (full 1 mL syringe scale). For larger reference amounts such as 2.5 mg, use a 3 mL graduated syringe and record 2.5 mL because 250 units is beyond a 1 mL syringe scale. For a full 5 mg reference amount, record 5 mL total and use appropriately sized lab transfer equipment.

CJC-1295 with DAC: 2 mg Vial, 2 mg/mL Target#

Vial contents: 2 mg lyophilised CJC-1295 with DAC. Target concentration: 2 mg/mL. Solvent volume required: 2 divided by 2 = 1.0 mL of BAC water.

Draw exactly 1.0 mL into a 1 mL syringe. Insert through the stopper, angle toward the wall, and transfer slowly. CJC-1295 with DAC is a relatively stable compound and dissolves quickly. The solution should clear within 60 seconds of gentle swirling. Inspect: clear, colourless. Label: "CJC-1295 DAC, 2 mg/mL, [date]." Refrigerate.

Reference aliquot arithmetic: 200 mcg = (200 divided by 2,000) times 100 = 10 units (0.10 mL). 500 mcg = 25 units (0.25 mL).

The vial contains 1.0 mL total = 100 units. At 10 units (200 mcg) per reference aliquot, this yields 10 aliquot records from one vial. The protocol timeline should be checked against the 30-day window.

Common Mistakes and How to Recognise Them#

Reconstitution errors fall into three categories: contamination errors, technique errors, and calculation errors. Each produces a different failure signature.

Contamination Errors#

Using an unsanitised surface. The failure is not immediately visible. The solution looks normal but may contain environmental bacteria or endotoxins. The result is a solution that appears clean but is not sterile. Maintain the habit of wiping the work surface with 70 percent isopropyl before every reconstitution session, not just occasionally.

Reusing a needle between vials. A needle that has passed through one rubber stopper deposits microscopic rubber particles and is no longer sterile. Use one needle per puncture event. This includes the separate needles for drawing from the BAC water vial and transferring solvent into the peptide vial; using the same needle for both is a contamination pathway.

Not wiping stoppers, or not allowing the alcohol to dry. Wet isopropyl alcohol driven into a vial by the needle introduces a foreign solvent. Dry stoppers are not optional.

Drawing from a BAC water vial past its 28-day post-puncture window. The benzyl alcohol preservative activity diminishes over time and repeated stopper punctures accumulate physical debris. Date the BAC water vial at first puncture and discard at 28 days regardless of remaining volume.

Technique Errors#

Shaking the vial. The most frequent mistake. Shaking generates foam through the surfactant effect of disturbed peptide chains, and the mechanical shear forces can denature the peptide structure. If you have accidentally shaken a vial, allow the foam to fully collapse before proceeding. If foam persists beyond 10 minutes, consider whether the surface tension has changed due to degradation, and document the appearance before discarding.

Aiming solvent directly onto the powder cake. A forceful water stream into the cake disrupts the porous structure and can aerosolise fine powder into the headspace where it is unrecoverable. Aim for the glass wall every time.

Reconstituting at the wrong temperature. Room temperature is correct. Hot water accelerates degradation. Cold water can cause the peptide to precipitate out of solution before it fully dissolves.

Reconstituting a vial that will not be consumed within the peptide's post-reconstitution window. A freshly mixed vial of BPC-157 does not last indefinitely. Reconstitute what you will use, not everything in the shipment.

Calculation Errors#

Wrong decimal placement. 5 mg/mL and 0.5 mg/mL differ by a factor of ten. A ten-fold concentration error produces a ten-fold aliquot-record error. Write down the calculation and confirm units before drawing.

Not accounting for a partially used vial. If you need to reconstitute a fresh vial mid-protocol, confirm the peptide mass in the new vial matches the label before assuming the same concentration ratio applies.

Forgetting to apply the correct unit conversion. mcg and mg are a factor of 1,000 apart. When calculating units from a concentration in mg/mL against a target reference amount in mcg, convert consistently. A 0.5 mg reference aliquot from a 2 mg/mL solution is 25 units; a 500 mcg reference aliquot from the same solution is also 25 units. These are the same mass written in different units, but the arithmetic can be confused when mixing notations.

Storage After Reconstitution: Temperature, Light, and Container#

Once reconstituted, consistent refrigeration is non-negotiable. The target range is 2 to 8 degrees Celsius. Place vials in the body of the refrigerator, not on the door. Door shelves undergo temperature cycling every time the fridge is opened; the main compartment maintains a more stable temperature. If temperature precision matters, place a small probe thermometer in the same compartment and verify over 24 to 48 hours.

Light degrades many peptide solutions, particularly those containing aromatic amino acid residues such as tryptophan, phenylalanine, and tyrosine. Store vials in an opaque container, a dark glass bottle, a cardboard box, or wrapped in aluminium foil.

Keep reconstituted peptide vials away from the freezer compartment of a frost-free refrigerator. Frost-free cycles involve brief periods of sub-zero temperature to prevent ice build-up; this freeze-thaw cycling damages peptide solutions. If you observe ice crystals forming near your storage vials, move them to a warmer shelf away from the freezer section.

A practical organisational habit: maintain a dedicated small tray in the refrigerator for reconstituted peptide vials. Labels face forward, sorted oldest-to-front, newest-to-back. This prevents accidentally drawing from a fresh vial while a near-expiry vial sits at the back of the shelf. The peptide storage and vial inspection checklist covers receipt condition, refrigerator positioning, vial inspection, temperature monitoring, and evidence capture across compound classes in detail.

Freeze-Thaw Damage: Why Repeated Cycles Degrade Reconstituted Peptides#

Freeze-thaw cycling is one of the most reliably documented causes of reconstituted peptide degradation. When a peptide solution freezes, ice crystals form within the liquid. These crystals have a mechanical effect: the expanding ice lattice physically displaces solute molecules, concentrating them into small pockets of unfrozen water. In these concentrated microenvironments, peptide chains are forced into proximity, encouraging aggregation and misfolding. Aggregated peptide chains do not disaggregate cleanly upon thawing; the damage is not reversible.

As the solution thaws, ice crystals melt unevenly, and the pH of the solution can shift transiently as buffer capacity changes. For unbuffered solutions, including most BAC water reconstitutions, these transient pH shifts can be significant enough to affect peptide conformation. In addition, the concentration oscillations during freeze-thaw cycles promote hydrolysis reactions at the newly exposed amide bonds.

The practical consequence: a peptide solution that has been frozen and thawed even once may have measurably reduced biological activity compared to the same solution kept at 4 degrees Celsius throughout. A solution through multiple freeze-thaw cycles is likely to contain aggregated material that will not re-dissolve, which may also produce particulate that is visible under bright-light inspection.

When Is Freezing Appropriate?#

If a vial will not be consumed within 28 to 30 days of reconstitution, some lab protocols separate validated working portions into labelled aliquot containers so each aliquot experiences at most one freeze-thaw event. This may matter for longer-interval non-clinical protocol work with compounds such as semaglutide and tirzepatide, where a single reconstituted vial can represent multiple protocol timepoints. Individually logged aliquots stored at -20 degrees Celsius and thawed once are easier to audit than repeatedly freeze-thawing the bulk vial.

When a preparation plan uses child aliquots, keep the label and thaw records as first-class evidence rather than side notes. The research peptide aliquot labeling template ties each child vial to the parent lot, concentration calculation, storage location, and discard/review rule; the research peptide freeze-thaw log template records each thaw event, out-of-storage duration, inspection note, and disposition without turning the record into use guidance.

For daily-interval peptides such as BPC-157, ipamorelin, and sermorelin, the 30-day refrigerated window is almost always sufficient without any freezing, assuming the vial is sized appropriately for the protocol's consumption rate.

The key principle: the lyophilised powder form tolerates frozen storage very well because the absence of water eliminates both ice crystal formation and aqueous degradation pathways. If a peptide is not needed for more than a few weeks, the better practice is to leave it sealed as powder and reconstitute fresh when needed, rather than reconstituting now and managing a solution through a freeze cycle.

When to Discard: Visual Signs and Time Limits by Peptide Type#

The decision to discard a reconstituted peptide vial should be made before each recorded aliquot event, not only at the end of the stated shelf life. Visual inspection is the primary tool; the 30-day guideline is a backstop, not a guarantee of quality.

Visual Inspection Protocol#

Before every recorded aliquot event, hold the vial at eye level against a bright light source. A well-documented reconstituted peptide solution should be:

• Clear (or faintly straw-coloured, depending on the compound)
• Free of particulate (no floating particles, fibres, or flecks)
• Consistent in colour with the day of reconstitution

Discard signals:

Cloudiness or turbidity. Any haziness, milkiness, or turbidity indicates either microbial growth or peptide precipitation. Both are discard signals without exception.

Visible particulate matter. Small floating particles may be rubber debris cored from the stopper by repeated needle punctures, or aggregated peptide. Either way, discard.

Colour change. A solution that was colourless at reconstitution and has since become yellow, brown, or pink has undergone chemical change. Oxidation of aromatic residues, bacterial metabolite production, and thermal degradation can all produce colour shifts.

Unusual odour. A properly reconstituted peptide in BAC water has a faint benzyl alcohol smell. A sour, yeasty, metallic, or sulphurous odour indicates contamination or degradation. A brief cautious sniff from a short distance is sufficient; do not inhale deeply from an unknown vial.

When in doubt, discard or quarantine under the lab's material-control procedure. Photographing questionable vials against a dark background before disposal creates a useful record if a supplier batch shows problems across multiple researchers, and it helps distinguish a reconstitution-technique problem from an upstream quality issue.

Time Limits by Compound#

BPC-157: The 30-day guideline applies, though many researchers use a more conservative 20-21 day window given published reports of faster solution degradation compared to engineered peptides. For a 5 mg vial with a 250 mcg reference aliquot record, this can map to roughly 20 aliquot events.

TB-500: The 30-day guideline is appropriate. Some researchers report stable solutions beyond 30 days under optimal refrigeration, but stretching past the stated window is not recommended.

Semaglutide and tirzepatide: GLP-1 class compounds have chemical modifications (fatty acid chains, linker chemistry) that confer greater molecular stability than unmodified peptides. The 30-day guideline is conservative for these compounds. For reference, pharmaceutical semaglutide pen devices (Ozempic, Wegovy) carry a 28-day post-first-use window at room temperature; at refrigerated temperatures, the window is extended further. Research peptide preparations should be treated at least as carefully as the pharmaceutical analogues.

CJC-1295 with DAC: The drug affinity complex contributes to in vivo stability and also confers better solution stability than non-DAC GHRH analogues. A standard 28-30 day window is appropriate.

Ipamorelin: Short peptide, good stability under refrigeration. The 28-30 day guideline is appropriate with no special considerations.

Sermorelin: A 29-amino acid peptide without the engineered stability features of longer compounds. A conservative 21-28 day window is appropriate, particularly if refrigerator temperature consistency cannot be verified.

Retatrutide: Limited published stability data specific to research-grade preparations. Apply the standard 28-30 day window and discard based on visual inspection if anything changes before that date.

Calculating Remaining Usable Volume from a Partially Used Vial#

As a vial is used over time, knowing how much peptide remains matters for protocol inventory planning and for deciding when to prepare a fresh vial.

Method 1: Track by units recorded#

After each aliquot event, record the units removed in a log. Sum the cumulative units and subtract from the total available at reconstitution.

Example: 5 mg BPC-157 reconstituted with 2 mL BAC water. Concentration = 2.5 mg/mL. Total volume = 2.0 mL = 200 units on a U-100 syringe. Total peptide = 5,000 mcg.

Day 1: 10 units recorded (250 mcg). Cumulative recorded: 10 units. Remaining: 190 units (4,750 mcg). Day 7: further 60 units recorded across the week. Cumulative recorded: 70 units. Remaining: 130 units (3,250 mcg).

This method requires no re-measuring of the vial and is accurate to within the measurement precision of the syringe.

Method 2: Visual Estimation Against the Vial#

Hold the vial at eye level against a light source. Observe the meniscus against the vial markings or estimated midpoint. For a 2 mL vial, the midpoint is 1 mL. Above midpoint means more than 1 mL remains; below means less. This is an approximate check rather than a precise measurement, useful for confirming that the unit-tracking log roughly matches the physical appearance.

Planning Protocol Consumption#

Design the protocol consumption schedule so the vial is exhausted before the discard date. For a BPC-157 vial with a 250 mcg reference aliquot, a 5 mg vial yields 20 aliquot records and falls within a 21-day conservative window if consumed daily. For a semaglutide vial with a 0.5 mg weekly reference aliquot, a 3 mg vial at 0.5 mg/mL yields six aliquot records across six weeks, which exceeds a 30-day window; plan for only the aliquots that fit the documented window and discard remaining volume at that point.

If the peptide quantity in a vial exceeds what can be consumed within the post-reconstitution window, consider whether the supplier offers smaller vial sizes, or whether reconstituting a smaller portion (by splitting the powder into two vials at the source) is practical. For most research peptides from Lynx Labs, multiple vial sizes are available, and choosing the size that matches the protocol's consumption window avoids systematic waste.

Reconstitution Documentation Handoff Checklist#

Before choosing a solvent or vehicle, use the research peptide solvent compatibility matrix to document supplier instructions, solvent lot, preservative exposure, pH or buffer constraints, vehicle-only controls, storage assumptions, and any assay-specific compatibility risk. This keeps the reconstitution record from becoming a vague mixing note when the real issue is solvent selection.

Use this checklist as the bridge between receiving records and any solution-preparation notes. It keeps the reconstitution math connected to the lot evidence instead of treating the vial as an anonymous powder.

Reconstitution record field matrix#

Use this matrix when another article links here as a documentation asset. It keeps the preparation record compact enough for a lab notebook while still preserving the facts that matter later.

Cluster handoff for related procurement pages#

Use this page as the solution-preparation node in the documentation graph. A buyer can arrive from a COA review, a supplier scorecard, a GLP-1 comparison matrix, a GH secretagogue comparison, or a recovery peptide comparison table. The handoff is the same: verify the current lot first, record receiving condition, calculate solvent volume, label the working solution, then attach storage and temperature notes to the same batch record. If the preparation creates multiple child vials, freezer portions, retained samples, or working dilutions, use the research peptide aliquot labeling template to keep each child ID tied to the parent lot, calculation record, storage location, freeze-thaw count, and discard/review rule.

That graph matters because reconstitution errors often look like biological differences later. A GLP-1 assay can be distorted by vial capacity, concentration, or freeze-thaw assumptions. A GH-axis comparison can be distorted if CJC, Sermorelin, Ipamorelin, or GHRP vials are prepared under different handling records. A recovery model can be distorted if BPC-157, TB-500, KPV, LL-37, or GHK-Cu lots are documented cleanly at receipt but poorly after solution preparation. Keep the workflow boring and auditable.

The useful output is not just a clear vial. It is a traceable record that lets a lab connect the final working solution back to the exact supplier lot, receipt condition, calculation, and storage assumption.

Rendering diagram...